Sun Pharma sees single-digit decline in revenues for FY18
On US FDA inspection, Shanghvi said on completion of re- inspection, the USFDA issued nine observations for the Halol facility and the company is currently in the process of implementing the requisite remediation steps.
Sep 03, 2017, 14:00 PM IST